Porphyria cutanea tarda concomitant with chronic hepatitis C

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access


Porphyrias form a group of rare metabolic diseases associated with disorders in the heme biosynthesis enzymes, leading to porphyrin accumulation in tissues. The disease is rare and is often diagnosed too late. The most incident is porphyria cutanea tarda. All patients with this condition should be tested for viral hepatites and hemochromatosis. A clinical case is presented: a patient with porphyria cutanea tarda associated with alcohol abuse and viral hepatitis C.

Full Text

Restricted Access

About the authors

N. P Teplyuk

I.M. Setchenov First Moscow State Medical University

119991, Moscow, Russia

Ekaterina Yu. Vertieva

I.M. Setchenov First Moscow State Medical University

Email: ivertieva@gmail.com
119991, Moscow, Russia
Candidate of Medical Sciences, Research Officer

D. V Ignatyev

I.M. Setchenov First Moscow State Medical University

119991, Moscow, Russia

I. S Dzhavakhishvili

I.M. Setchenov First Moscow State Medical University

119991, Moscow, Russia


  1. Thadani H., Deacon A., Peters T. Diagnosis and management of porphyria. Br. Med. J. 2000; 320 (7250): 1647-51.
  2. Халдин А.А., Олисова О.Ю., Белоусова Т.А. К вопросу о диагностике поздней кожной порфирии. Российский журнал кожных и венерических болезней. 2004; 6: 32-6.
  3. Lim H.W. Pathogenesis of photosensitivity in the cutaneous porphyrias. J. Invest. Dermatol. 2005; 124(1): 16-7.
  4. Вольф К., Голдсмит Л.А., Кац С.И., Джилкрест Б.А., Паллер Э.С., Леффель Д.Дж. Дерматология Фицпатрика в клинической практике. Пер. с англ. М.: Изд. Панфилова; БИНОМ; 2012. т.2: 1343-74.
  5. Franke K., Fikentscher R. Die Bedeutung der quantitativen Porphyrinbestimmung mit der Lumineszenzmessung für die Prüfung der Leberfunktion und für Ernährungsfragen. Münchener Medizinische Wochenschrift. 1935; 82: 171-2.
  6. Goldberg A., Rimington C. Diseases of porphyrin metabolism. Illinois: Thomas Springfield; 1962: 19-20.
  7. Bloomer J.R. The hepatic porphyries: pathogenesis, manifestations, and management. Gastroenterology. 1976; 71(4): 689-701.
  8. McColl K.E., Thompson G.G., Moore M.R., Goldberg A. Acute ethanol ingestion and haem biosynthesis in healthy subjects. Eur. J. Clin. Invest. 1980; 10(2, Pt 1): 107-12.
  9. Doss M.O., Kuhnel A., Gross U. Alcohol and porphyrin metabolism. Alcohol. Alcohol. 2000; 35(2): 109-25.
  10. Balwani M., Desnick R.J. The orphyries: advances in diagnosis and treatment. Blood. 2012; 120(23): 4496-504. doi: 10.1182/blood-2012-05-423186.
  11. James M.F., Hift R.J. Porphyrias. Br. J. Anaesth. 2000; 85(1): 143-53.
  12. Palmieri C., Vigushin D.M., Peters T.J. Managing malignant disease in atients with porphyria. Q. J. M. 2004; 97(3): 115-26.
  13. Casanova-Gonzalez M.J., Trapero-Marugan M., Jones E.A., Moreno-Otero R. Liver disease and erythropoietic protoporphyria: a concise review. Wld J. Gastroenterol. 2010; 16(36): 4526-31.



Abstract - 31

PDF (Russian) - 0


Article Metrics

Metrics Loading ...



Copyright (c) 2016 Teplyuk N.P., Vertieva E.Y., Ignatyev D.V., Dzhavakhishvili I.S.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies